Source: Pulse2.0

MIG Capital: Bio-Fabricated Silk Protein Materials Company AMSilk Extends Funding Round To 54 Million

AMSilk GmbH - the world's first industrial supplier of bio-fabricated silk protein materials - announced it has successfully raised an additional €25 million in an extended Series C funding round. The post Bio-Fabricated Silk Protein Materials Company AMSilk Extends Funding Round To €54 Million appeared first on Pulse 2.0.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Merage's photo - Co-Founder & CEO of MIG

Co-Founder & CEO

Richard Merage

CEO Approval Rating

90/100

Read more